OCULAR MYASTHENIA GRAVIS
Clinical trials for OCULAR MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for OCULAR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to find best drug to stop eye muscle weakness from spreading
Disease control Recruiting nowThis study looks at different immunosuppressant drugs to treat ocular myasthenia gravis, a condition that causes droopy eyelids and double vision. Researchers will follow 200 adults with new-onset eye muscle weakness to see which treatment works best to control symptoms and preve…
Matched conditions: OCULAR MYASTHENIA GRAVIS
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo therapy aims to stop eye muscle disease from spreading
Disease control Recruiting nowThis study tests whether starting steroids right away, followed by rituximab if symptoms return, can prevent eye muscle weakness from spreading to other muscles in people with ocular myasthenia gravis. About 128 adults diagnosed within the last 6 months will be randomly assigned …
Matched conditions: OCULAR MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated May 14, 2026 12:03 UTC